Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Measurement of urinary canine S100A8/A9 and S100A12 concentrations as candidate biomarkers of lower urinary tract neoplasia in dogs.

Heilmann RM, Wright ZM, Lanerie DJ, Suchodolski JS, Steiner JM.

J Vet Diagn Invest. 2014 Jan;26(1):104-12. doi: 10.1177/1040638713516625. Epub 2014 Jan 7.

PMID:
24398905
2.

Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.

Heilmann RM, McNiel EA, Grützner N, Lanerie DJ, Suchodolski JS, Steiner JM.

BMC Vet Res. 2017 Apr 21;13(1):112. doi: 10.1186/s12917-017-1032-5.

3.

Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs.

Henry CJ, Tyler JW, McEntee MC, Stokol T, Rogers KS, Chun R, Garrett LD, McCaw DL, Higginbotham ML, Flessland KA, Stokes PK.

Am J Vet Res. 2003 Aug;64(8):1017-20.

PMID:
12926595
4.

S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study.

Ludwig S, Stephan C, Lein M, Loening SA, Jung K.

Prostate. 2007 Sep 1;67(12):1301-7.

PMID:
17626245
5.

Evaluation of microsatellite instability in urine for the diagnosis of transitional cell carcinoma of the lower urinary tract in dogs.

Sotirakopoulos AJ, Armstrong PJ, Heath L, Madrill NJ, McNiel EA.

J Vet Intern Med. 2010 Nov-Dec;24(6):1445-51. doi: 10.1111/j.1939-1676.2010.0617.x. Epub 2010 Oct 12.

6.

Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases.

Lorenz E, Muhlebach MS, Tessier PA, Alexis NE, Duncan Hite R, Seeds MC, Peden DB, Meredith W.

Respir Med. 2008 Apr;102(4):567-73. doi: 10.1016/j.rmed.2007.11.011. Epub 2007 Dec 27.

7.
8.

Canine prostate carcinomas express markers of urothelial and prostatic differentiation.

LeRoy BE, Nadella MV, Toribio RE, Leav I, Rosol TJ.

Vet Pathol. 2004 Mar;41(2):131-40.

PMID:
15017026
9.

A population study of neutering status as a risk factor for canine prostate cancer.

Bryan JN, Keeler MR, Henry CJ, Bryan ME, Hahn AW, Caldwell CW.

Prostate. 2007 Aug 1;67(11):1174-81.

PMID:
17516571
10.

S100 Calgranulins in inflammatory arthritis.

Perera C, McNeil HP, Geczy CL.

Immunol Cell Biol. 2010 Jan;88(1):41-9. doi: 10.1038/icb.2009.88. Epub 2009 Nov 24. Review.

PMID:
19935766
11.

Canine transitional cell carcinoma.

Mutsaers AJ, Widmer WR, Knapp DW.

J Vet Intern Med. 2003 Mar-Apr;17(2):136-44. Review.

12.

Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder.

Ebbing J, Mathia S, Seibert FS, Pagonas N, Bauer F, Erber B, Günzel K, Kilic E, Kempkensteffen C, Miller K, Bachmann A, Rosenberger C, Zidek W, Westhoff TH.

World J Urol. 2014 Dec;32(6):1485-92. doi: 10.1007/s00345-013-1227-8. Epub 2013 Dec 31.

PMID:
24378824
14.

Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma.

Sheryka E, Wheeler MA, Hausladen DA, Weiss RM.

Urology. 2003 Jul;62(1):162-6.

PMID:
12837459
15.

Cutaneous metastasis of transitional cell carcinoma in 12 dogs.

Reed LT, Knapp DW, Miller MA.

Vet Pathol. 2013 Jul;50(4):676-81. doi: 10.1177/0300985812465326. Epub 2012 Nov 6.

PMID:
23136183
16.

Development and analytic validation of an immunoassay for the quantification of canine S100A12 in serum and fecal samples and its biological variability in serum from healthy dogs.

Heilmann RM, Lanerie DJ, Ruaux CG, Grützner N, Suchodolski JS, Steiner JM.

Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):200-9. doi: 10.1016/j.vetimm.2011.09.011. Epub 2011 Oct 6.

PMID:
22030158
17.

Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

Mohammed SI, Craig BA, Mutsaers AJ, Glickman NW, Snyder PW, deGortari AE, Schlittler DL, Coffman KT, Bonney PL, Knapp DW.

Mol Cancer Ther. 2003 Feb;2(2):183-8.

18.
19.

Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.

Tydén H, Lood C, Gullstrand B, Jönsen A, Nived O, Sturfelt G, Truedsson L, Ivars F, Leanderson T, Bengtsson AA.

Rheumatology (Oxford). 2013 Nov;52(11):2048-55. doi: 10.1093/rheumatology/ket263. Epub 2013 Aug 13.

PMID:
23942785
20.

High levels of S100A12 are associated with recent plaque symptomatology in patients with carotid atherosclerosis.

Abbas A, Aukrust P, Dahl TB, Bjerkeli V, Sagen EB, Michelsen A, Russell D, Krohg-Sørensen K, Holm S, Skjelland M, Halvorsen B.

Stroke. 2012 May;43(5):1347-53. doi: 10.1161/STROKEAHA.111.642256. Epub 2012 Mar 1. Erratum in: Stroke. 2013 Jul;44(7):e82. Sørensen, Kirsten Krohg [corrected to Krohg-Sørensen, Kirsten].

Supplemental Content

Support Center